Professor has been appointed as a
commissioner of the Commission on Human Medicines (CHM) for four
years from 3 March 2025.
Three other commissioners of the Commission on Human Medicines
have also been reappointed, with their new terms due to begin in
May.
The CHM is an advisory non-departmental public body which is
sponsored by the Department of Health and
Social Care (DHSC).
The CHM advises ministers on the safety, efficacy and quality of
medicines.
Three commissioners have been reappointed:
- Professor Amanda Adler has been reappointed for a further two
years from 1 May 2025.
- Professor Steve Cunningham has been reappointed for a further
two years from 1 May 2025.
- Professor Yvonne Perrie has been reappointed for a further
four years from 1 May 2025.
The appointments will involve a time commitment of approximately
22 days per year including 11 meetings. Remuneration for the
roles will be at a rate of £325 per meeting.
All appointments are made in accordance with the Cabinet Office
Code of Governance for Public Appointments.
The regulation of public appointments against the requirements of
this code is carried out by the Commissioner for Public
Appointments.
The appointments are made on merit and political activity played
no part in the decision process. However, in accordance with the
code, there is a requirement for appointees' political activity
(if any declared) to be made public.
None of the appointees have declared any political activity.
